Taro Pharmaceutical Industries Ltd
TARO
Company Profile
Business description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Contact
14 Hakitor Street
P.O. Box 10347
Haifa Bay
Haifa 2624761
ISRT: +972 48475700
E: William.Coote@taro.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
1,554
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,028.60 | 32.90 | 0.41% |
CAC 40 | 8,225.80 | 16.52 | 0.20% |
DAX 40 | 18,716.42 | 25.80 | -0.14% |
Dow JONES (US) | 39,558.11 | 126.60 | 0.32% |
FTSE 100 | 8,428.13 | 13.14 | 0.16% |
HKSE | 19,073.71 | 41.35 | -0.22% |
NASDAQ | 16,511.18 | 122.94 | 0.75% |
Nikkei 225 | 38,491.15 | 135.09 | 0.35% |
NZX 50 Index | 11,561.03 | 57.06 | -0.49% |
S&P 500 | 5,246.68 | 25.26 | 0.48% |
S&P/ASX 200 | 7,762.10 | 35.30 | 0.46% |
SSE Composite Index | 3,145.77 | 2.25 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sayona Mining Ltd SYA | 0.05 | 0.00 | 0.00% |
Pantoro Ltd PNR | 0.08 | 0.00 | 0.00% |
Core Lithium Ltd CXO | 0.15 | 0.01 | -4.69% |
Arafura Rare Earths Ltd ARU | 0.20 | 0.01 | 5.41% |
Renascor Resources Ltd RNU | 0.12 | 0.02 | 15.00% |
Capitol Health Ltd CAJ | 0.25 | 0.00 | 0.00% |
Medibank Private Ltd MPL | 3.75 | 0.03 | 0.67% |
Imugene Ltd IMU | 0.07 | 0.00 | -1.41% |
Pilbara Minerals Ltd PLS | 4.00 | 0.03 | 0.63% |
South32 Ltd S32 | 3.66 | 0.04 | 0.97% |